In a significant move within the pharmaceutical manufacturing industry, Veranova has announced a substantial $30 million investment to enhance its Devens, Massachusetts facility. This strategic expansion is designed to bolster Veranova’s capabilities in developing and manufacturing antibody-drug
In a strategic move blending technological innovation with environmental consciousness, SGD Pharma has invested over €20 million to advance its facility in Zhanjiang, China. This significant refurbishment is not merely about upgrading the equipment but is part of a greener manifesto—committing to
The landscape of biopharmaceutical manufacturing in Ireland has recently welcomed an impressive addition with the inauguration of the National Institute for Bioprocessing Research and Training's (NIBRT) new facility. This state-of-the-art establishment in Dublin, conceived with a robust €21 million
In a significant move aimed at boosting the development of cell and gene therapies, Bionova Scientific, a part of the Asahi Kasei Group, has announced an ambitious $100 million investment. This investment will see the creation of a new state-of-the-art plasmid DNA (pDNA) production facility in The
AstraZeneca, the renowned pharmaceutical giant, has unveiled plans to invest $1.5 billion in a cutting-edge antibody drug conjugate (ADC) manufacturing facility in Singapore, marking a significant milestone in the company's history. The state-of-the-art factory is poised to become operational in
Solvias' announcement of opening a new biotech facility in Research Triangle Park, North Carolina, has sparked excitement and anticipation within the Raleigh-Durham area. The region, already renowned for its concentration of tech and biotech firms, is poised to add another jewel to its crown with
